Ligand Pharmaceuticals Statistics
Total Valuation
Lucid Group has a market cap or net worth of EUR 5.97 billion. The enterprise value is 7.50 billion.
Market Cap | 5.97B |
Enterprise Value | 7.50B |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 3.07B |
Shares Outstanding | n/a |
Shares Change (YoY) | +22.46% |
Shares Change (QoQ) | +0.71% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.55 |
PB Ratio | 1.64 |
P/TBV Ratio | 2.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.88 |
EV / Sales | 9.42 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -2.89 |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.64.
Current Ratio | 2.58 |
Quick Ratio | 1.94 |
Debt / Equity | 0.64 |
Debt / EBITDA | n/a |
Debt / FCF | -0.90 |
Interest Coverage | -55.14 |
Financial Efficiency
Return on equity (ROE) is -54.39% and return on invested capital (ROIC) is -27.57%.
Return on Equity (ROE) | -54.39% |
Return on Assets (ROA) | -21.93% |
Return on Invested Capital (ROIC) | -27.57% |
Return on Capital Employed (ROCE) | -40.88% |
Revenue Per Employee | 116,329 |
Profits Per Employee | -382,786 |
Employee Count | 6,800 |
Asset Turnover | 0.11 |
Inventory Turnover | 3.03 |
Taxes
Income Tax | -2.26M |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 42.99 |
Average Volume (20 Days) | 2,286 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.51 |
Income Statement
In the last 12 months, Lucid Group had revenue of EUR 791.04 million and -2.60 billion in losses. Loss per share was -0.96.
Revenue | 791.04M |
Gross Profit | -785.21M |
Operating Income | -2.55B |
Pretax Income | -1.96B |
Net Income | -2.60B |
EBITDA | -2.24B |
EBIT | -2.55B |
Loss Per Share | -0.96 |
Balance Sheet
The company has 2.41 billion in cash and 2.33 billion in debt, giving a net cash position of 72.32 million.
Cash & Cash Equivalents | 2.41B |
Total Debt | 2.33B |
Net Cash | 72.32M |
Net Cash Per Share | n/a |
Equity (Book Value) | 3.64B |
Book Value Per Share | 0.67 |
Working Capital | 2.06B |
Cash Flow
In the last 12 months, operating cash flow was -1.92 billion and capital expenditures -677.14 million, giving a free cash flow of -2.60 billion.
Operating Cash Flow | -1.92B |
Capital Expenditures | -677.14M |
Free Cash Flow | -2.60B |
FCF Per Share | n/a |
Margins
Gross margin is -99.26%, with operating and profit margins of -322.76% and -247.07%.
Gross Margin | -99.26% |
Operating Margin | -322.76% |
Pretax Margin | -247.36% |
Profit Margin | -247.07% |
EBITDA Margin | -283.00% |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Lucid Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.46% |
Shareholder Yield | n/a |
Earnings Yield | -43.57% |
FCF Yield | -43.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Lucid Group has an Altman Z-Score of -1.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.87 |
Piotroski F-Score | 3 |